Drug comparisons
Saxagliptin vs Troglitazone
Compare Saxagliptin (current DPP-4) vs Troglitazone (withdrawn TZD) for diabetes. Differences in safety, especially liver toxicity, and current availability.
No comparison dimensions are available for this page.
Clinical context
When evaluating current DPP-4 inhibitors against historically used thiazolidinediones for type 2 diabetes management.
Bottom line
Saxagliptin is the currently available and safer choice over the withdrawn Troglitazone.
All medication comparisons